The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers.
10.5051/jpis.2010.40.1.39
- Author:
Jae Mok LEE
1
;
Towia A LIBERMANN
;
Je Yoel CHO
Author Information
1. Department of Periodontology, Kyungpook National University School of Dentistry, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
Cell differentiation;
Core binding factor alpha 1 subunit;
Osteoblasts
- MeSH:
Alkaline Phosphatase;
Animals;
Antigens, Differentiation;
Bone and Bones;
Bone Morphogenetic Proteins;
Cell Differentiation;
Cell Proliferation;
Core Binding Factor Alpha 1 Subunit;
Erythroblasts;
Humans;
Luciferases;
Osteoblasts;
Osteocalcin;
Osteogenesis;
Osteopontin;
Polymerase Chain Reaction;
Proteins;
Rats;
RNA, Messenger;
Transcription Factors;
Transfection
- From:Journal of Periodontal & Implant Science
2010;40(1):39-44
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Bone tissues for clinical application can be improved by studies on osteoblast differentiation. Runx2 is known to be an important transcription factor for osteoblast differentiation. However, bone morphogenetic protein (BMP)-2 treatment to stimulate Runx2 is not sufficient to acquire enough bone formation in osteoblasts. Therefore, it is necessary to find other regulatory factors which can improve the transcriptional activity of Runx2. The erythroblast transformation-specific (ETS) transcription factor family is reported to be involved in various aspects of cellular proliferation and differentiation. METHODS: We have noticed that the promoters of osteoblast differentiation markers such as alkaline phosphatase (Alp), osteopontin (Opn), and osteocalcin (Oc) contain Ets binding sequences which are also close to Runx2 binding elements. Luciferase assays were performed to measure the promoter activities of these osteoblast differentiation markers after the transfection of Runx2, myeloid Elf-1-like factor (MEF), and Runxs+MEF. Reverse-transcription polymerase chain reaction was also done to check the mRNA levels of Opn after Runx2 and MEF transfection into rat osteoblast (ROS) cells. RESULTS: We have found that MEF, an Ets transcription factor, increased the transcriptional activities of Alp, Opn, and Oc. The addition of Runx2 resulted in the 2- to 6-fold increase of the activities. This means that these two transcription factors have a synergistic effect on the osteoblast differentiation markers. Furthermore, early introduction of these two Runx2 and MEF factors significantly elevated the expression of the Opn mRNA levels in ROS cells. We also showed that Runx2 and MEF proteins physically interact with each other. CONCLUSIONS: Runx2 interacts with MEF proteins and binds to the promoters of the osteoblast markers such as Opn nearby MEF to increase its transcriptional activity. Our results also imply that osteoblast differentiation and bone formation can be increased by activating MEF to elicit the synergistic effect of Runx2 and MEF.
